MetaCap

Who Owns Lexicon Pharmaceuticals Stock?

NASDAQ: LXRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.53-0.14 (-8.38%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
84.35%
Institutional holders
205
  • Institutions 84.3%
  • Insiders 1.1%
  • Public and other 14.5%

Who owns Lexicon Pharmaceuticals stock?

Institutional investors own about 84.3% of Lexicon Pharmaceuticals's shares, spread across 205 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.13% of LXRX.

The largest institutional holders are Artal Group S.A. (39.34%), FMR, LLC (14.99%) and Siren, L.L.C. (9.95%). Together, the top 10 institutions control 77.6% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their LXRX positions and 5 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of LXRX

Lexicon Pharmaceuticals top institutional holders
InstitutionShares% HeldChange
Artal Group S.A.175.16M39.34%0.0%
FMR, LLC66.74M14.99%+28.9%
Siren, L.L.C.44.30M9.95%0.0%
Blackrock Inc.16.80M3.77%-3.2%
Sessa Capital IM, L.P.14.36M3.23%-24.3%
Vanguard Capital Management LLC9.73M2.19%-1.7%
State Street Corporation7.47M1.68%+51.9%
Geode Capital Management, LLC5.89M1.32%-5.6%
Vanguard Portfolio Management LLC2.89M0.65%+22.6%
Northern Trust Corporation1.94M0.44%-1.5%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of LXRX

Lexicon Pharmaceuticals top fund holders
FundShares% Held
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund20.70M4.65%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund7.08M1.59%
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund6.07M1.36%
iShares Trust-iShares Russell 2000 ETF5.91M1.33%
Fidelity Select Portfolios-Select Biotechnology Portfolio5.71M1.28%
Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund5.07M1.14%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund2.72M0.61%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund2.57M0.58%
SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF2.26M0.51%
iShares Trust-iShares Russell 2000 Growth ETF2.13M0.48%

Frequently asked questions

Who is the largest shareholder of Lexicon Pharmaceuticals?

Artal Group S.A. is the largest institutional shareholder of LXRX, owning 39.34% of shares outstanding (175.16M shares) as of its latest 13F filing.

What percentage of Lexicon Pharmaceuticals is owned by institutions?

Institutions own about 84.3% of LXRX shares and 85.3% of the public float.

How much of Lexicon Pharmaceuticals do insiders own?

Insiders, such as officers and directors, own about 1.13% of LXRX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related